Indicators

Latest News about Ruby

Recent news which mentions Ruby

< Previous 1 2 3 4 Next >

Stocks That Hit 52-Week Lows On Tuesday

July 26, 2022

89 Biggest Movers From Friday

June 21, 2022

12 Health Care Stocks Moving In Friday's After-Market Session

June 17, 2022

Will Another Enlivex Innovation Break The Glass Ceiling For Solid Tumor Treatments?

June 14, 2022

91 Biggest Movers From Friday

June 13, 2022

83 Biggest Movers From Yesterday

June 09, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

June 08, 2022

50 Stocks Moving In Wednesday's Mid-Day Session

June 08, 2022

69 Biggest Movers From Friday

June 06, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

June 03, 2022

Ruby CEO on lessons learned after ransomware strike on hosting vendor

May 23, 2022

Stocks That Hit 52-Week Lows On Tuesday

May 17, 2022

What 6 Analyst Ratings Have To Say About Rubius Therapeutics

May 10, 2022

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves

May 10, 2022

Earnings Scheduled For May 10, 2022

May 10, 2022

60 Biggest Movers From Yesterday

April 26, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

April 25, 2022

3 Stocks Under $3 Insiders Are Aggressively Buying

April 25, 2022

60 Biggest Movers From Yesterday

April 22, 2022

Stocks That Hit 52-Week Lows On Thursday

April 21, 2022

12 Health Care Stocks Moving In Thursday's Intraday Session

April 21, 2022

Stocks That Hit 52-Week Lows On Wednesday

April 20, 2022

Expert Ratings for Rubius Therapeutics

April 11, 2022

SVB Leerink Maintains Market Perform Rating for Rubius Therapeutics, Lowers Price Target To $3

April 11, 2022

Guggenheim Maintains Buy Rating for Rubius Therapeutics, Lowers Price Target To $5

April 11, 2022

Rubius Shares Plunge After Early Data From RTX-240 Solid Tumor Trial

April 08, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

April 08, 2022

28 Stocks Moving In Friday's Mid-Day Session

April 08, 2022

The Daily Biotech Pulse: Evotec Earns $16M Milestone Payment, Genmab Hit With Adverse Tribunal Ruling, Quidel Announces Above-Consensus Q1 Revenues And More

April 08, 2022

87 Biggest Movers From Yesterday

March 10, 2022

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.